SCHEMBL19497907

SCHEMBL19497907

C=CC(=O)OCCCCCCOc1ccc(C(=O)Oc2ccc(-c3ccc(CCC)cc3)c(C=O)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ THRB P10828 5/20 0.44
▸ PTPN11 Q06124 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ PRSS1 P07477 1/20 0.38
▸ ACR P10323 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ RARB P10826 4/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19497953 0.99 MAPT (0.46) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL19497950 0.97 MAPT (0.46) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL18200278 0.92 MAPT (0.44) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL19497864 0.91 MAPT (0.45) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL19497943 0.91 ALDH1A1 (0.40) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL19352701 0.91 HTT (0.41) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL19497859 0.90 MAPT (0.45) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL19844264 0.87 MAPT (0.44) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL19497904 0.87 THRB (0.45) MAPTSMN1; SMN2THRBPTPN11NPC1
SCHEMBL16379472 0.86 THRB (0.60) MAPTSMN1; SMN2THRBNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723952-B2 Polymerizable compound and optically anisotropic body DIC CORPORATION (JP) 2020-07-28 — — US disclosed
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2017-10-26 — — US disclosed
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY SMC4, PHOSPHO1, SMCHD1 MAPT 21/4885SMN1; SMN2 1598/4885THRB 4883/4885
US-10723952-B2 Polymerizable compound and optically anisotropic body SMC4, SMCHD1, PHOSPHO1 MAPT 17/4885SMN1; SMN2 1468/4885THRB 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback